The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Vertigo


Psychiatry related information on Vertigo


High impact information on Vertigo

  • Hydroxychloroquine-induced vertigo [11].
  • Ondansetron for intractable vertigo complicating acute brainstem disorders [12].
  • We report a patient with neurosarcoidosis who developed bilateral benign paroxysmal positional vertigo (BPPV) of the posterior canals, deafness, and absent responses to conventional caloric and rotational vestibular testing [13].
  • This is a review of selected aspects of the history of the vestibular system (J. E. Purkyne, E. Mach, A. Crum-Brown) and of our current understanding of vestibular malfunction in clinical vertigo syndromes [14].
  • Amiodarone-induced severe prolonged head-positional vertigo and vomiting [15].

Chemical compound and disease context of Vertigo

  • Cinnarizine and flunarizine are selective calcium blockers that have been used to treat and prevent vertigo [16].
  • Cinnarizine and flunarizine are piperazine derivatives with calcium antagonist and anticonvulsant properties and are used widely in the treatment of vertigo and circulatory disorders [17].
  • Treatment with intratympanic injection of gentamicin can be beneficial when vertigo persists despite optimal medical management [18].
  • In patients with acute vertigo, transdermal hyoscine and oral meclozine were equally efficacious and both were significantly better than placebo in reducing the number of attacks of vertigo [19].
  • Side-effects are typical of those of other tetracyclines, but minocycline has been associated with a high incidence of vertigo in some studies [20].

Biological context of Vertigo


Anatomical context of Vertigo


Gene context of Vertigo


Analytical, diagnostic and therapeutic context of Vertigo


  1. Vestibular vertigo. A form of polyneuritis? Adour, K.K., Sprague, M.A., Hilsinger, R.L. JAMA (1981) [Pubmed]
  2. Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. Edmonson, J.H., Buckner, J.C., Long, H.J., Loprinzi, C.L., Schaid, D.J. J. Natl. Cancer Inst. (1989) [Pubmed]
  3. The neurotoxicity of antibacterial agents. Snavely, S.R., Hodges, G.R. Ann. Intern. Med. (1984) [Pubmed]
  4. Progressive ataxia due to a missense mutation in a calcium-channel gene. Yue, Q., Jen, J.C., Nelson, S.F., Baloh, R.W. Am. J. Hum. Genet. (1997) [Pubmed]
  5. Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia. Solary, E., Caillot, D., Chauffert, B., Casasnovas, R.O., Dumas, M., Maynadie, M., Guy, H. J. Clin. Oncol. (1992) [Pubmed]
  6. Phase II evaluation of merbarone in renal cell carcinoma. Flanigan, R.C., Saiers, J.H., Wolf, M., Kraut, E.H., Smith, A.Y., Blumenstein, B., Crawford, E.D. Investigational new drugs. (1994) [Pubmed]
  7. Prevalence of neurological disorders in a Japanese town. Nakashima, K., Yokoyama, Y., Shimoyama, R., Saito, H., Kuno, N., Sano, K., Rin, Y., Adachi, Y., Urakami, K., Oshima, T., Takeshita, K., Takahashi, K. Neuroepidemiology. (1996) [Pubmed]
  8. Clinical experience in acute overdosage of diphenidol. Yang, C.C., Deng, J.F. J. Toxicol. Clin. Toxicol. (1998) [Pubmed]
  9. Effects of intratympanic injection of latanoprost in Meniere's disease: a randomized, placebo-controlled, double-blind, pilot study. Rask-Andersen, H., Friberg, U., Johansson, M., Stjernschantz, J. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. (2005) [Pubmed]
  10. Psychological findings in benign paroxysmal positional vertigo and psychogenic vertigo. Nagarkar, A.N., Gupta, A.K., Mann, S.B. The Journal of otolaryngology. (2000) [Pubmed]
  11. Hydroxychloroquine-induced vertigo. Prince, D.S., Hardin, J.G. JAMA (1975) [Pubmed]
  12. Ondansetron for intractable vertigo complicating acute brainstem disorders. Rice, G.P., Ebers, G.C. Lancet (1995) [Pubmed]
  13. Selective vestibular damage in neurosarcoidosis. von Brevern, M., Lempert, T., Bronstein, A.M., Kocen, R. Ann. Neurol. (1997) [Pubmed]
  14. Man in motion. Historical and clinical aspects of vestibular function. A review. Brandt, T. Brain (1991) [Pubmed]
  15. Amiodarone-induced severe prolonged head-positional vertigo and vomiting. Arbusow, V., Strupp, M., Brandt, T. Neurology (1998) [Pubmed]
  16. Flunarizine- and cinnarizine-induced extrapyramidal reactions. Micheli, F., Pardal, M.F., Gatto, M., Torres, M., Paradiso, G., Parera, I.C., Giannaula, R. Neurology (1987) [Pubmed]
  17. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism. Veitch, K., Hue, L. Mol. Pharmacol. (1994) [Pubmed]
  18. Ménière's disease. Minor, L.B., Schessel, D.A., Carey, J.P. Curr. Opin. Neurol. (2004) [Pubmed]
  19. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Clissold, S.P., Heel, R.C. Drugs (1985) [Pubmed]
  20. Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use. Brogden, R.N., Speight, T.M., Avery, G.S. Drugs (1975) [Pubmed]
  21. Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency. A study in general practice comprising 2772 patients. Memin, Y. Drugs (1987) [Pubmed]
  22. Effects of clonidine on sinus node function in man. Thormann, J., Neuss, H., Schlepper, M., Mitrovic, V. Chest (1981) [Pubmed]
  23. Salmeterol-induced vertigo. López-Guillen, A., Marquès, L., López-Llorente, M.T., Pastor, E., Figueras, A. Eur. Respir. J. (1994) [Pubmed]
  24. Multiple positional nystagmus suggests multiple canal involvement in benign paroxysmal vertigo. Lopez-Escamez, J.A., Molina, M.I., Gamiz, M., Fernandez-Perez, A.J., Gomez, M., Palma, M.J., Zapata, C. Acta Otolaryngol. (2005) [Pubmed]
  25. Dose-dependent effect of betahistine on the vestibulo-ocular reflex: a double-blind, placebo controlled study in patients with paroxysmal vertigo. Kingma, H., Bonink, M., Meulenbroeks, A., Konijnenberg, H. Acta Otolaryngol. (1997) [Pubmed]
  26. History of "epileptic vertigo": its medical, social, and forensic problems. Bladin, P.F. Epilepsia (1998) [Pubmed]
  27. Theoretical models for the mechanisms of benign paroxysmal positional vertigo. House, M.G., Honrubia, V. Audiol. Neurootol. (2003) [Pubmed]
  28. Effects of cinnarizine on calcium and pressure-dependent potassium currents in guinea pig vestibular hair cells. Düwel, P., Haasler, T., Jüngling, E., Duong, T.A., Westhofen, M., Lückhoff, A. Naunyn Schmiedebergs Arch. Pharmacol. (2005) [Pubmed]
  29. Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques. Frohman, E.M., Kramer, P.D., Dewey, R.B., Kramer, L., Frohman, T.C. Mult. Scler. (2003) [Pubmed]
  30. Rheumatoid arthritis and vertebral artery occlusion: a case report with angiographic and magnetic resonance demonstration. Loeb, M., Bookman, A., Mikulis, D. J. Rheumatol. (1993) [Pubmed]
  31. Positional vertigo and macroscopic downbeat positioning nystagmus in spinocerebellar ataxia type 6 (SCA6). Yabe, I., Sasaki, H., Takeichi, N., Takei, A., Hamada, T., Fukushima, K., Tashiro, K. J. Neurol. (2003) [Pubmed]
  32. Progressive late-onset sensorineural hearing loss and vestibular impairment with vertigo (DFNA9/COCH): longitudinal analyses in a belgian family. Lemaire, F.X., Feenstra, L., Huygen, P.L., Fransen, E., Devriendt, K., Van Camp, G., Vantrappen, G., Cremers, C.W., Wackym, P.A., Koss, J.C. Otol. Neurotol. (2003) [Pubmed]
  33. Familial migraine with vertigo: no mutations found in CACNA1A. Kim, J.S., Yue, Q., Jen, J.C., Nelson, S.F., Baloh, R.W. Am. J. Med. Genet. (1998) [Pubmed]
  34. Cerebellar infarction. Clinical and anatomic observations in 66 cases. Kase, C.S., Norrving, B., Levine, S.R., Babikian, V.L., Chodosh, E.H., Wolf, P.A., Welch, K.M. Stroke (1993) [Pubmed]
  35. Stapes prosthesis: evaluation with CT. Swartz, J.D., Lansman, A.K., Berger, A.S., Wolfson, R.J., Bell, G., Popky, G.L., Swartz, N.G. Radiology. (1986) [Pubmed]
  36. Pharmacology of vertigo/nystagmus/oscillopsia. Straube, A. Curr. Opin. Neurol. (2005) [Pubmed]
  37. Minocycline for prophylaxis of infection with Neisseria meningitidis: high rate of side effects in recipients. Drew, T.M., Altman, R., Black, K., Goldfield, M. J. Infect. Dis. (1976) [Pubmed]
  38. Neurologic perspectives of otosclerosis. Thomas, J.E., Cody, D.T. Mayo Clin. Proc. (1981) [Pubmed]
  39. Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Marill, K.A., Walsh, M.J., Nelson, B.K. Annals of emergency medicine. (2000) [Pubmed]
  40. Rational use of EEG in adults in clinical practice. Airoldi, L., Beghi, E., Bogliun, G., Crespi, V., Frattola, L. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. (1999) [Pubmed]
WikiGenes - Universities